drugset / Trial / NCT00000297

Effects of Labetalol on Nicotine Administration in Humans - 14

NCT00000297

Double-blindTreatment

Summary

The purpose of this study is to investigate the effects of labetalol in response to intravenous nicotine

Timeline

Start
1998-10
Primary completion
Completion
2001-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Labetalol Small molecule 100 mg Oral
Subject Labetalol Small molecule 200 mg Oral

Indications